The US health regulator has said Lupin and Cadila Healthcare are recalling 1.11 lakh units of Duloxetine delayed-release capsules and 19,812 bottles of Paroxetine tablets from US market. Lupin is recalling the capsules on account of failed dissolution specification. Zydus Pharmaceuticals, a unit of Cadila, is recalling the tablets after different pills were found in bottles labeled Paroxetine.